1,753
Views
24
CrossRef citations to date
0
Altmetric
Report

FANCI is a negative regulator of Akt activation

, , , &
Pages 1134-1143 | Received 13 Jan 2016, Accepted 18 Feb 2016, Published online: 20 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Agnieszka T. Kawashima, Cassandra Wong, Gema Lordén, Charles C. King, Pablo Lara-Gonzalez, Arshad Desai, Anne-Claude Gingras & Alexandra C. Newton. (2021) The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. Molecular and Cellular Biology 41:3.
Read now
Claudia M. Wever, Dominique Geoffrion, Bruno M. Grande, Stephen Yu, Miguel Alcaide, Maryse Lemaire, Yasser Riazalhosseini, Josée Hébert, Christina Gavino, Donald C. Vinh, Tina Petrogiannis-Haliotis, Svetlana Dmitrienko, Koren K. Mann, Ryan D. Morin & Nathalie A. Johnson. (2018) The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples. Leukemia & Lymphoma 59:9, pages 2159-2174.
Read now

Articles from other publishers (22)

Harini Hariharan, Saurav Panicker & Satish Ramalingam. 2023. Cancer Genes: Volume 2. Cancer Genes: Volume 2 62 106 .
Caitlin T. Fierheller, Wejdan M. Alenezi, Corinne Serruya, Timothée Revil, Setor Amuzu, Karine Bedard, Deepak N. Subramanian, Eleanor Fewings, Jeffrey P. Bruce, Stephenie Prokopec, Luigi Bouchard, Diane Provencher, William D. Foulkes, Zaki El Haffaf, Anne-Marie Mes-Masson, Marc Tischkowitz, Ian G. Campbell, Trevor J. Pugh, Celia M. T. Greenwood, Jiannis Ragoussis & Patricia N. Tonin. (2023) Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene. Genes 14:2, pages 277.
Crossref
Valentina Sora, Adrian Otamendi Laspiur, Kristine Degn, Matteo Arnaudi, Mattia Utichi, Ludovica Beltrame, Dayana De Menezes, Matteo Orlandi, Ulrik Kristoffer Stoltze, Olga Rigina, Peter Wad Sackett, Karin Wadt, Kjeld Schmiegelow, Matteo Tiberti & Elena Papaleo. (2022) RosettaDDGPrediction for high‐throughput mutational scans: From stability to binding . Protein Science 32:1.
Crossref
Jill E. Hunter, Amy E. Campbell, Scott Kerridge, Callum Fraser, Nicola L. Hannaway, Saimir Luli, Iglika Ivanova, Philip J. Brownridge, Jonathan Coxhead, Leigh Taylor, Peter Leary, Megan S. R. Hasoon, Claire E. Eyers & Neil D. Perkins. (2022) Up-regulation of the PI3K/AKT and RHO/RAC/PAK signalling pathways in CHK1 inhibitor resistant Eµ-Myc lymphoma cells. Biochemical Journal 479:19, pages 2131-2151.
Crossref
Maria-Magdalena Georgescu, Stephen G. Whipple & Christina M. Notarianni. (2022) Novel neoplasms associated with syndromic pediatric medulloblastoma: integrated pathway delineation for personalized therapy. Cell Communication and Signaling 20:1.
Crossref
Jiguang Zhang, Jingdong Wang, Jincheng Wu, Jianyuan Huang, Zhaoxian Lin & Xing Lin. (2022) UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT. Oncology Reports 48:2.
Crossref
Ilgin Cagnan, Mustafa Keles, Ayse Gokce Keskus, Melike Tombaz, Ozge Burcu Sahan, Fatima Aerts-Kaya, Duygu Uckan-Cetinkaya, Ozlen Konu & Aysen Gunel-Ozcan. (2021) Global miRNA expression of bone marrow mesenchymal stem/stromal cells derived from Fanconi anemia patients. Human Cell 35:1, pages 111-124.
Crossref
Caitlin T. Fierheller, Laure Guitton-Sert, Wejdan M. Alenezi, Timothée Revil, Kathleen K. Oros, Yuandi Gao, Karine Bedard, Suzanna L. Arcand, Corinne Serruya, Supriya Behl, Liliane Meunier, Hubert Fleury, Eleanor Fewings, Deepak N. Subramanian, Javad Nadaf, Jeffrey P. Bruce, Rachel Bell, Diane Provencher, William D. Foulkes, Zaki El Haffaf, Anne-Marie Mes-Masson, Jacek Majewski, Trevor J. Pugh, Marc Tischkowitz, Paul A. James, Ian G. Campbell, Celia M. T. Greenwood, Jiannis Ragoussis, Jean-Yves Masson & Patricia N. Tonin. (2021) A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene. Genome Medicine 13:1.
Crossref
Amir Ata Saei, Christian M. Beusch, Pierre Sabatier, Juan Astorga Wells, Hassan Gharibi, Zhaowei Meng, Alexey Chernobrovkin, Sergey Rodin, Katja Näreoja, Ann-Gerd Thorsell, Tobias Karlberg, Qing Cheng, Susanna L. Lundström, Massimiliano Gaetani, Ákos Végvári, Elias S. J. Arnér, Herwig Schüler & Roman A. Zubarev. (2021) System-wide identification and prioritization of enzyme substrates by thermal analysis. Nature Communications 12:1.
Crossref
Tengyong Wang, Xiaoxuan Chen, Fangqi Jing, Zehua Li, Huaicheng Tan, Yiqiao Luo & Huashan Shi. (2021) Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values. Pathology - Research and Practice 228, pages 153654.
Crossref
Sudong Zhan, Jolene Siu, Zhanwei Wang, Herbert Yu, Tedros Bezabeh, Youping Deng, Wei Du & Peiwen Fei. (2021) Focal Point of Fanconi Anemia Signaling. International Journal of Molecular Sciences 22:23, pages 12976.
Crossref
Liyun Ji, Jihong Fu, Jie Hao, Yin Ji, Huiyu Wang, Zeyuan Wang, Peng Wang & Hua Xiao. (2021) Proteomics analysis of tissue small extracellular vesicles reveals protein panels for the reoccurrence prediction of colorectal cancer. Journal of Proteomics 249, pages 104347.
Crossref
Kellie A. Lemoine, Julianna M. Fassas, Shirag H. Ohannesian & Nicole H. Purcell. (2021) On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart. Cellular Signalling 86, pages 110097.
Crossref
Timothy R. BaffiKsenya Cohen-KatsenelsonAlexandra C. Newton. (2021) PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell Signaling. Annual Review of Pharmacology and Toxicology 61:1, pages 723-743.
Crossref
Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak, Michał Mikuła, Jerzy Ostrowski, Agnieszka Śliwińska & Aneta Rogalska. (2020) PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality—An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness. International Journal of Molecular Sciences 21:24, pages 9715.
Crossref
Maria-Magdalena Georgescu & Adriana Olar. (2020) Genetic and histologic spatiotemporal evolution of recurrent, multifocal, multicentric and metastatic glioblastoma. Acta Neuropathologica Communications 8:1.
Crossref
Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak & Aneta Rogalska. (2020) Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer. Journal of Hematology & Oncology 13:1.
Crossref
Weigang Chen, Chang Gao, Yong Liu, Ying Wen, Xiaoling Hong & Zunnan Huang. (2020) Bioinformatics Analysis of Prognostic miRNA Signature and Potential Critical Genes in Colon Cancer. Frontiers in Genetics 11.
Crossref
Shicai Fan, Jianxiong Tang, Nan Li, Ying Zhao, Rizi Ai, Kai Zhang, Mengchi Wang, Wei Du & Wei Wang. (2019) Integrative analysis with expanded DNA methylation data reveals common key regulators and pathways in cancers. npj Genomic Medicine 4:1.
Crossref
Raymond Che, Jun Zhang, Manoj Nepal, Bing Han & Peiwen Fei. (2018) Multifaceted Fanconi Anemia Signaling. Trends in Genetics 34:3, pages 171-183.
Crossref
Kanaka Durga Devi Gorrepati, Blaz Lupse, Karthika Annamalai, Ting Yuan, Kathrin Maedler & Amin Ardestani. (2018) Loss of Deubiquitinase USP1 Blocks Pancreatic β-Cell Apoptosis by Inhibiting DNA Damage Response. iScience 1, pages 72-86.
Crossref
Manoj Nepal, Raymond Che, Chi Ma, Jun Zhang & Peiwen Fei. (2017) FANCD2 and DNA Damage. International Journal of Molecular Sciences 18:8, pages 1804.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.